CN114699439B - Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof - Google Patents

Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof Download PDF

Info

Publication number
CN114699439B
CN114699439B CN202210348145.5A CN202210348145A CN114699439B CN 114699439 B CN114699439 B CN 114699439B CN 202210348145 A CN202210348145 A CN 202210348145A CN 114699439 B CN114699439 B CN 114699439B
Authority
CN
China
Prior art keywords
flavor
self
mannose
gel
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210348145.5A
Other languages
Chinese (zh)
Other versions
CN114699439A (en
Inventor
邱丽颖
朱雪锐
侯豹
文嫄媛
戚梦婷
蔡维维
张建峰
宗咏花
于晓依
米玛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202210348145.5A priority Critical patent/CN114699439B/en
Publication of CN114699439A publication Critical patent/CN114699439A/en
Application granted granted Critical
Publication of CN114699439B publication Critical patent/CN114699439B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a five-flavor mannose self-heating gel patch with an anti-inflammatory effect and a preparation method thereof, belonging to the field of pharmaceutical preparations. The formula of the matrix of the self-heating gel patch is as follows: 7.5% of sodium polyacrylate NP800,0.33% of Gan Qiangji aluminum, 0.05% of diethylamine tetraacetic acid, 4.6% of talcum powder, 0.38% of titanium dioxide, 37.52% of glycerol, 1.13% of carboxymethyl cellulose (2200), 4.69% of tween, 0.28% of tartaric acid, and the content of the manna gel plaster for each patch is 2.5%. And the combined application of the gel patch and the warm patch is provided for the first time, so that the condition that a user is stressed due to supercooling of muscles when using the gel patch can be effectively alleviated. The self-heating gel paste has the advantages of luster, small exudation degree of non-woven fabrics, strong skin affinity, aromatic smell, repeated uncovering and pasting and no pollutant residue. Has remarkable therapeutic effect on the auricle swelling inflammation model of mice.

Description

Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof
Technical Field
The invention relates to a five-flavor mannose self-heating gel patch with an anti-inflammatory effect and a preparation method thereof, belonging to the field of biological medicine preparations.
Background
The five-flavor sweet dew is a classical prescription recorded in the Tibetan medicine classic "four-part medical dictionary", and has the main efficacy of treating diseases within the scope of 'long' diseases prescribed by Tibetan medicine such as rheumatoid arthritis. The compound prescription mainly comprises five medicines of ephedra herb, juniper, tarragon, water cypress branch and azalea. Most of the literature reports that the chemical components of the compound medicine mainly contain artemisinin, kaempferide, quercetin, ephedrine hydrochloride and the like.
The five-flavor manna medicated bath is a prescription frequently used by Tibetan medicines, and the defects that the use mode is limited by conditions and the Chinese medicinal bath is not easy to carry are gradually revealed along with the gradual simplification of modern life. However, five-flavor manna has very abundant pharmacological activity and very great research value, and no effective medicine for rheumatic and rheumatoid arthritis appears in the existing market. Therefore, the five-flavor manna medicated bath preparation is prepared into the five-flavor manna self-heating gel patch, which is convenient for patients with rheumatic and rheumatoid arthritis to use, and solves the problem that the current rheumatic and rheumatoid arthritis has no special medicine. The gel emplastrum can accommodate traditional Chinese medicine powder and extract, and has the advantages of relatively simple preparation process, short production period and the like. Spontaneous heating has effects of promoting drug permeation and improving drug effect.
Disclosure of Invention
In order to solve the problem that the use mode of the existing five-flavor mannose as a medicated bath is limited by conditions, the invention firstly provides the five-flavor mannose self-heating gel patch with anti-inflammatory effect, which consists of five-flavor mannose gel and self-heating patch; the five-flavor manna gel comprises the following components: 7.5% of sodium polyacrylate NP800,0.33% of Gan Qiangji aluminum, 0.05% of diethylamine tetraacetic acid, 4.6% of talcum powder, 0.38% of titanium dioxide, 37.52% of glycerol, 1.13% of carboxymethyl cellulose (2200), 4.69% of tween, 0.28% of tartaric acid and self-heating patches, wherein the content of medicinal powder in each patch of five-component manna gel patches is 2.5%.
In one embodiment of the invention, the five-flavor manna powder is prepared by taking 60g of rhododendron anthopogonoides, water cypress branches, juniper, sweet wormwood and Tibetan ephedra, respectively, extracting for 2 times under the water bath of 60 ℃, extracting for two hours in a material-liquid ratio of 1:10, combining the extracting solutions, filtering, decompressing, steaming and drying in a rotary way to obtain the five-flavor manna powder.
The invention also provides a preparation method of the five-flavor mannose self-heating gel patch, which comprises the following steps: gel paste is prepared according to the optimal proportion of matrix auxiliary materials, phase A (sodium polyacrylate NP800, aluminum glycollate, sodium diethylamine tetraacetate, talcum powder, titanium dioxide, glycerol and hydroxymethyl cellulose) and phase B (five-flavor mannite powder, water and tween) are respectively prepared into uniform suspension, phase C (water and tartaric acid) is added into phase C, phase B is added, the mixture is uniformly mixed (quick mixing), the mixture is coated (the coating is sealed to avoid air flow), and the mixture is left for 12 hours to solidify.
The invention also provides a five-flavor mannose self-heating gel patch, wherein the drug loading rate is 2.5%.
The invention also provides the combined application of the five-flavor mannose self-heating gel patch by using the self-heating patch and the gel patch.
The invention also provides application of the five-flavor manna gel patch in preparation of medicines with anti-inflammatory effect.
In one embodiment of the invention, the anti-inflammatory effect is preferably anti-rheumatic and rheumatoid arthritis.
The invention also provides a pharmaceutical composition comprising the five-flavor mannose self-heating gel patch.
The beneficial effects of the invention are that
The invention prepares the five-flavor mannose aqueous extract into the gel patch, is convenient for patients to use and carry at any time, evaluates the drug effect of the five-flavor mannose self-heating gel patch through a mouse auricle swelling model experiment, and the test result shows that the five-flavor mannose self-heating gel patch has remarkable treatment effect on the mouse auricle swelling inflammation model.
Drawings
FIG. 1 five-component mannose self-heating gel paste process flow diagram
FIG. 2 skin response of New Zealand rabbits at the site of administration
Detailed Description
Five-ingredient mannose self-heating gel patch appearance property scoring: according to the evaluation index of the hydrogel patch of the 2015 edition of Chinese pharmacopoeia, the appearance property grading index of the hydrogel patch comprises paste gloss, pollution, exudation degree of non-woven fabrics, skin affinity and smell.
Five-ingredient mannose self-heating gel paste excipient test: according to the method of the fourth part 0122 of the 2015 edition of Chinese pharmacopoeia, 3 pieces of five-flavor manna gel paste are taken, and after the five-flavor manna gel paste is placed for 24 hours, if no flow phenomenon exists on the paste surface, the paste surface meets the pharmacopoeia standard.
Measurement of initial adhesion of five-flavor mannose self-heating gel patches: according to the first method under the fourth part 0952 of the 2015 edition of the Chinese pharmacopoeia. The sample (together with the packaging material) should be left for more than 2 hours at 18-25 ℃ and 40% -70% relative humidity prior to testing. The surfaces of the inclined plate and the stainless steel ball are scrubbed by wiping materials dipped with absolute ethyl alcohol, and are carefully scrubbed by clean dust-free cloth, and the inclined plate and the stainless steel ball are repeatedly cleaned for more than 3 times until the surfaces of the inclined plate and the stainless steel ball are clean through visual inspection. The inclined plate is adjusted according to the inclined angle of 15 degrees, and the horizontal state of the bottom of the experimental device is kept. And 3 pieces of test sample are taken, the back lining of the test sample is respectively fixed on the inclined plate by using a double-sided adhesive tape, wherein the upper end of the test sample is positioned at the horizontal line-down position of the inclined plate, and the test sample is flatly attached to the plate. After removing the cover lining of the test sample, finishing the test as soon as possible, reserving 5cm on the middle paste surface, sequentially placing steel balls with different numbers on an initial line, enabling the distance between the steel balls and the paste to be 1cm, freely falling from the top end of the inclined surface, and recording the maximum number of steel balls capable of being stuck, wherein the number of steel balls with the number of 8 or more can be stuck.
Five-ingredient mannose self-heating gel patch containing paste measurement standard: taking 8 pieces of test sample, removing the cover liner, precisely weighing, and placing in a beaker. Adding appropriate amount of water, heating and boiling to separate the backing from the paste, taking out the backing, washing with water until the backing has no residual paste, and air drying. Drying at 105deg.C for 30min, transferring to a dryer, cooling for 30min, weighing, and removing weight to obtain ointment. According to a second method for determining the paste content in the four parts 0122 of 2015 of Chinese pharmacopoeia, the average paste content of each tablet is about 10.0g, and the paste content is 85% -115% of the marked paste content. Namely converted into 100cm according to the marked quantity 2 Is added to the paste.
Five-ingredient mannose self-heating gel patch cumulative transdermal rate experiment: and (3) measuring the transdermal content of flavonoid, saponins and polysaccharide substances in the five-flavor manna gel patch by adopting a transdermal diffusion cell. The temperature of the transdermal diffusion tester is controlled to be 37+/-0.1 ℃, and the rotating speed of the magnetic stirrer is controlled to be 180+/-1.0 r2min- 1 . The volume of the receiving tank is 8mL, and the diffusion area is 1.77cm 2 . The magnetic stirrer is placed in a receiving tank, and the prepared in-vitro mouse skin (1.77 cm) 2 ) The upper end of the receiving tank is horizontally placed, the stratum corneum is upwards, and then the releasing tank is fixed on the receiving tank by a clip. Removing the anti-adhesive layer, tightly adhering to the skin of mice, removing air bubbles between the plaster and skin, fixing between the diffusion chamber and the receiving chamber of the diffusion cell, facing the receiving chamber, adding physiological saline solution as receiving solution to scale line via sampling tube by syringe, stirring at constant speed (180 r 2 min -1 ) 8mL of the receiving solution was extracted at 0.5, 1, 1.5, 2, 4, and 6 hours, respectively, and 8mL of fresh receiving solution was added.
The received solution was filtered with a 0.45 μm filter membrane, and the cumulative transdermal rate (%) was calculated by the following formula:
L n =Q n /W×100
Q n to accumulate transdermal flux, C n For the concentration of the sample at the nth time point, V is the receiving pool volume, C i For the concentration of the sample at the ith time point, V 0 For each sampled volume, L n For accumulating the transdermal rate, W is the content of flavonoids, saponins and polysaccharides in the five-flavor manna gel patch.
Five-ingredient mannose self-heating gel patch irritation experiment: the skin irritation of the self-heating water gel patch is examined by referring to the related requirements of the traditional Chinese medicine natural medicine local irritation and hemolysis research technical guidelines. 6 New Zealand rabbits were selected, and half of the male and female rabbits were removed from the two sides of the spinal column 24 hours before administration, taking care that the epidermis was not damaged. Self-heating hydrogel patch and blank patch (3 cm×3cm) are applied to rabbit hair removal area skin, covered with cellophane, and fixed with medical adhesive tape. Removing the patch 24h after administration, removing residual matrix, observing skin reaction at the administration position at 1, 24, 48 and 72h, and scoring according to the guideline rule, wherein the score is 0 score without erythema, 0 score without oedema and 0-0.49.
Five-flavor manna water extract: reflux extracting 60g of Rhododendron anthoxylum, herba Selaginellae, juniper, herba Artemisiae Annuae and herba Ephedrae respectively in water bath at 60deg.C for 2 times with a feed-liquid ratio of 1:10, extracting for two hours each time, mixing extractive solutions, filtering, and vacuum rotary evaporating to dry to obtain fructus Schisandrae chinensis water extract dry powder.
The present invention is further described below with reference to examples, but embodiments of the present invention are not limited thereto.
Example 1: five-ingredient mannose self-heating gel patch drug-loading quantity screening test
The five-flavor manna self-heating hydrogel patch drug-loading rate is screened by a rat joint inflammation model. Firstly, acute joint inflammation of rats is induced by carrageenan, then the rats are randomly divided into three groups, marked at the ankle joints of the rats, and the foot volume of the rats is measured by using a drainage method. The center of the foot palm of the rat is subcutaneously injected with carrageenan in a telecentric direction, the right foot of each group of rats is coated with five flavors Gan Zhiji with different concentrations, and the left is a blank control group. The ankle volumes of the rats were measured at 2h, 4h, 6h, and 24h, respectively, and the swelling degree and swelling inhibition rate were calculated. Swelling inhibition = control swelling degree-dosing swelling degree)/control swelling degree.
TABLE 1 five-ingredient manna formulations with different concentrations have remarkable inhibiting effect on rat plantar swelling
Note that: p <0.05 compared to the blank; * P <0.01.
As can be seen from table 1, the five-ingredient manna preparation with the mass percentage of 2.5% has a remarkable inhibiting effect on the plantar swelling of rats and has a remarkable treatment effect on the arthritis of rats. Therefore, the five-flavor mannose self-heating gel paste is kept to contain 2.5% of five-flavor mannose powder, and then the mixture ratio of auxiliary materials is changed to screen the final five-flavor mannose self-heating gel paste formula.
Example 2 five-ingredient manna self-heating gel paste process flow and matrix screening
In order to make the medicine in the paste permeate human skin to the maximum extent, be convenient to use and effectively store, the gel plaster is divided into 3 layers, namely a backing layer: the non-woven fabric is mainly used as a carrier of the paste; paste layer: is a main component of the gel emplastrum, contains water molecules and water-soluble polymer skeleton structures of medicines, and generates viscosity in the use process so as to be closely attached to the skin; anti-sticking layer: protecting the paste layer and selecting a polypropylene film by using release paper. The process flow diagram is shown in figure 1.
The proportion of the matrix is the core of the gel patch research, and the selection of the matrix raw materials has great influence on the formation of the gel patch matrix. The matrix of the gel patch mainly comprises: thickening agent, humectant, filler, crosslinking agent, surfactant, antiseptic, and antioxidant can be added as required. The matrix should have no influence on the main drug components, and should not cause injury to human body, and also have suitable viscoelasticity. The study uses the mixing difficulty, coating difficulty, pH value and strength analysis of the basic formula as evaluation indexes of the five-flavor mannose gel patch to determine the dosage of each matrix in the five-flavor mannose basic formula.
From the previous laboratory study and related literature, the following materials were selected as matrix materials for the five-flavor manna gel patch as shown in table 2.
Table 2 matrix material and action of five-ingredient manna gel patch
Matrix material Action
Sodium polyacrylate NP800 Thickening agent
Gan Qiangji aluminum Crosslinking agent
Diethylamine tetraacetic acid sodium salt Complexing agent
Talc powder Filler (B)
TiO2 Crosslinking agent
Glycerol Humectant type
Carboxymethyl cellulose (2200) Adhesion promoters
Tartaric acid PH regulator
Example 3 five-ingredient manna self-heating gel paste matrix proportion screening and specific flow
Gan Qiangji aluminium proportional screening
As shown in Table 3, aluminum glycinate was the single variable, and Gan Qiangji aluminum was the variable, with the amounts of other materials remaining unchanged. The content of the aluminum glycinate in the prescription 1 is 0.188 percent, and the content of the aluminum glycinate in the prescription 2 is 0.328 percent.
Table 3 comparison of matrix ratios of recipe 1 and recipe 2
As shown in table 4, prescription 2, which was moderately strong and had a higher pH, was selected for further optimization based on the intensity analysis.
Table 4 comparison of ease of mixing, ease of coating, pH and strength analysis for prescriptions 1 and 2
Tween factor screening
Tween is a single variable, and the phase B main medicine is considered to be difficult to mix with water, so that 4.7% tween is added as prescription 3 on the basis of prescription 2.
Table 5 comparison of matrix ratios of recipe 2 and recipe 3
As shown in table 6. Formula 3 adds 4.7% tween based on formula 2, which can accelerate the B-phase mixing speed.
Table 6 comparison of ease of mixing, ease of coating, pH and strength analysis for prescriptions 2 and 3
Hydroxymethyl cellulose factor screening
As shown in table 7, the hydroxymethyl cellulose in the C phase was transferred to the a phase for mixing, considering that the C phase was uniformly mixed for a long time.
Table 7 comparison of matrix ratios of recipe 2 and recipe 4
As shown in Table 8, after the hydroxymethyl cellulose in phase C is transferred to phase A, the mixing time of phase C is shortened, and the operation time is reduced.
Table 8 comparison of ease of mixing, ease of coating, pH and strength analysis for prescriptions 2 and 4
As shown in Table 9, in the case of coating in the formulations 1 to 4, the paste was easily left on the backing due to the long coagulation time and small cohesion, and the content of the hydroxymethyl cellulose was increased from 0.56% to 1.13% and 2.81%.
Table 9 comparison of matrix ratios for prescriptions 4, 5 and 6
As shown in table 10, by comparison, when the hydroxymethyl cellulose content was 1.13%, the cohesion of the paste was moderate, the coating was easy, and the uniformity was good.
Table 10 comparison of the ease of mixing, ease of coating, pH and strength analysis for prescriptions 4, 5 and 6
According to the optimized result, the optimal matrix of the five-flavor manna gel patch is selected and the ratio is shown in table 11:
table 11 five-ingredient manna gel patch optimal matrix proportion
Example 4 five-ingredient manna self-heating gel patch evaluation of efficacy by mouse auricle swelling model experiment
Modeling of mouse auricle swelling due to xylene: the right ear of the mouse is coated with 100 mu l of dimethylbenzene (50 mu l/surface), the left ear is not treated, after 30min of inflammation, the thickness of the ears of the mouse is measured, the mouse is killed by neck removal, the ear disc is taken out from the same part of the left ear and the right ear by an 8mm puncher, the weight of the ear disc is weighed, and the ear swelling degree is calculated.
The mouse auricle swelling model is divided into four groups: model group, model+shizandra manna self-heating patch gel, model+shizandra manna gel, model+heating patch. After xylene inflammation is coated, the model group is not treated, and three groups of horses are attached with five-flavor manna self-heating paste gel, five-flavor manna gel and a heating paste. After 30min, the thickness of the ears of the mice is measured, the mice are killed by cervical removal, the ear discs are taken from the same positions of the left ear and the right ear by using an 8mm puncher, the weight of the ear discs is weighed, and the ear swelling degree is calculated.
Table 12 mouse auricle swelling model experiment swelling degree and swelling inhibition rate
The results in Table 12 show that the five-flavor mannose self-heating gel patch has remarkable treatment effect on the auricle swelling inflammation model of the mice.
Three batches of five-flavor mannose self-heating gel patches are prepared according to the optimal matrix proportion, and the physical and chemical properties of the five-flavor mannose self-heating gel patches are detected, so that the results show that:
gel patch appearance: the five-flavor mannose self-heating gel paste has the advantages of luster, small exudation degree of non-woven fabrics, strong skin affinity, aromatic smell, repeated uncovering and pasting, no pollutant residue and accordance with pharmacopoeia standards.
Gel paste shaping properties: 3 pieces of five-flavor manna self-heating hydrogel paste are taken, and after the paste is placed for 24 hours, the paste surface has no flowing phenomenon and meets the pharmacopoeia standard.
Gel paste primary adhesion: the five-flavor manna gel paste can be maximally stuck to the 11 # ball by the measurement of a CYZ-G tester. Meets the standards of Chinese pharmacopoeia.
Gel patch contains the following components: according to a second method for determining the paste content in the four parts 0122 of 2015 of Chinese pharmacopoeia, the average paste content of each tablet is about 10.0g, and the paste content is 85% -115% of the marked paste content. Namely, the paste content is converted into 100cm2 according to the marked amount. The gel patch contains 8.58-11.29 g of paste and accords with the standards of Chinese pharmacopoeia.
Gel patch 6h cumulative transdermal rate of active substance: the accumulated transdermal rate of flavonoid substances is 23.01%, the accumulated transdermal rate of saponins substances is 16.4%, and the accumulated transdermal rate of glucose substances is 21.25%.
Gel patch irritation experiment: results figure 2 shows that 6 rabbits showed no erythema and edema after 24 hours of administration of the self-heating gel blank patch and the self-heating hydrogel patch, with a total score of 0 points, indicating that the self-heating hydrogel patch was non-irritating. Meets the pharmacopoeia standard.
Example 5 pharmaceutical composition comprising five-ingredient manna self-heating gel patch
In order to further expand the application prospect of the five-flavor mannose self-heating gel patch, other acceptable pharmaceutical compositions can be prepared by matching other auxiliary materials and carriers, including a mode of combined use with other medicines.
While the invention has been described with reference to the preferred embodiments, it is not limited thereto, and various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.

Claims (5)

1. A preparation method of five-flavor mannose self-heating gel paste with anti-inflammatory effect is characterized in that the five-flavor mannose self-heating gel paste consists of five-flavor mannose gel paste and self-heating paste; the five-flavor mannose gel patch is divided into 3 layers, namely a back lining layer, a paste layer and an anti-sticking layer, wherein the back lining layer is made of non-woven fabrics, and the anti-sticking layer is made of polypropylene films; the five-flavor manna gel paste body composition comprises the following components: 7.5% of sodium polyacrylate NP800,0.33% of Gan Qiangji aluminum, 0.05% of sodium diethylamine tetraacetate, 4.6% of talcum powder, 0.38% of titanium dioxide, 37.52% of glycerol, 1.13% of carboxymethyl cellulose 2200,4.69% of tween, 0.28% of tartaric acid, 2.5% of shizandra berry mannose powder and the balance of water;
the five-flavor mannose powder is obtained by the following method: reflux extracting Rhododendron anthoxylum, herba Sambuci Chiensis branch, juniper, herba Artemisiae Annuae and herba Ephedrae respectively at 60g in water bath at 60deg.C for 2 times with a feed-liquid ratio of 1:10, each time for two hours, mixing extractive solutions, filtering, and steaming under reduced pressure to obtain five-flavor manna powder;
the preparation method of the five-flavor mannose self-heating gel paste layer comprises the following steps:
phase a: sodium polyacrylate NP800, aluminum glycinate, sodium diethylamine tetraacetate, talcum powder, titanium dioxide, glycerol and hydroxymethyl cellulose, phase B: five-flavor manna powder, water, tween and phase C: preparing water and tartaric acid into uniform suspension respectively, adding phase A into phase C, adding phase B, mixing, coating, and standing for 12 hr for solidification.
2. According to claim 1The preparation method of the gel patch is characterized in that the five-flavor mannose self-heating gel patch has the paste content of 8.58g/100 cm 2 -11.29g/100 cm 2
3. The method of claim 1, wherein the post-coating seal prevents air flow.
4. The use of five-ingredient manna self-heating gel patch prepared by the method of claim 1 in the preparation of a medicament with anti-inflammatory effect.
5. The five-flavor mannose self-heating gel patch prepared by the preparation method of claim 1.
CN202210348145.5A 2022-04-01 2022-04-01 Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof Active CN114699439B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210348145.5A CN114699439B (en) 2022-04-01 2022-04-01 Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210348145.5A CN114699439B (en) 2022-04-01 2022-04-01 Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114699439A CN114699439A (en) 2022-07-05
CN114699439B true CN114699439B (en) 2023-08-08

Family

ID=82171979

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210348145.5A Active CN114699439B (en) 2022-04-01 2022-04-01 Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114699439B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106063802A (en) * 2015-04-23 2016-11-02 中国医学科学院药物研究所 Cacumen Myricariae Germanicae effective site, Its Preparation Method And Use
CN113413451A (en) * 2021-06-30 2021-09-21 贵州大学 Evodia rutaecarpa and ginger emplastrum and preparation method thereof
CN113577125A (en) * 2021-08-27 2021-11-02 西藏藏医药大学 A Chinese medicinal ointment with antiinflammatory effect, and its preparation method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106063802A (en) * 2015-04-23 2016-11-02 中国医学科学院药物研究所 Cacumen Myricariae Germanicae effective site, Its Preparation Method And Use
CN113413451A (en) * 2021-06-30 2021-09-21 贵州大学 Evodia rutaecarpa and ginger emplastrum and preparation method thereof
CN113577125A (en) * 2021-08-27 2021-11-02 西藏藏医药大学 A Chinese medicinal ointment with antiinflammatory effect, and its preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
藏药浴治疗类风湿性关节炎149例;柯长永;中医外治杂志;18(04);20-21 *

Also Published As

Publication number Publication date
CN114699439A (en) 2022-07-05

Similar Documents

Publication Publication Date Title
CN103919967B (en) Sanguis Draxonis compound recipe and the application in preparation treatment more wound medicine thereof
CN108744025A (en) It is a kind of to be used to promote antioxygenic property hydrogel of wound healing and its preparation method and application
CN104983989A (en) Traditional Chinese medicine drug for treating dysmenorrheal and gel paste and preparation method thereof
CN112022919A (en) Percutaneous-absorption artemisia vulgaris oil carrier gel and preparation method thereof
CN102038733B (en) Externally-used traditional Chinese medicine for treating hypertrophic scar and preparation method thereof
CN105477341A (en) Liquid adhesive bandage and preparation method thereof
CN114699439B (en) Five-flavor mannose self-heating gel patch with anti-inflammatory effect and preparation method thereof
CN115887603B (en) Gel emplastrum for treating blood stasis arthralgia and preparation method thereof
CN101890121A (en) External medicinal composition for treating acute soft tissue injury and preparation method and application thereof
CN102872288B (en) Frankincense rheumatism aerosol for curing rheumatism bone ache and preparation method thereof
CN106822377A (en) A kind of compound osteitis bar cloth patch and preparation method thereof
CN107320699A (en) A kind of Chinese medicine compound prescription micro emulsion gels and its production and use
CN110559258A (en) Tetrahydroberberine gel, preparation method thereof and transdermal rate detection method
CN1321655C (en) Gel of Chinese traditional medicine for treating cervicitis, colpitis and preparing method
CN1306842A (en) Preparation of shaolin plaster for rheumatism and wound
CN113908139B (en) Preparation method of rhizoma corydalis total alkaloid gel paste
CN108926549A (en) Rivastigmine gel emplastrum and preparation method thereof
CN114601959A (en) Medical skin care dressing and preparation method and application thereof
CN1739682A (en) Nudiflorous beautyberry soft capsule for body cavity and its prepn
CN104814944A (en) Transdermal patch for preventing and treating lumbar disc herniation and preparation method thereof
CN110302183B (en) Compound gel plaster for diminishing inflammation and pain and preparation method thereof
CN108030862A (en) A kind of oral cavity Chinese medicine film and preparation method thereof
CN116173168B (en) Sustained-release gel ointment for dispelling wind and cold, relaxing tendons and activating blood circulation, and relieving swelling and pain and preparation method thereof
Jain et al. Formulation and evaluation of TDDS of Indian medicinal plant
CN102590432B (en) Detection method for medicine for curing cold nature yellow water disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant